Loading organizations...
MedAvail delivers technology-enabled pharmacy solutions, centered on its proprietary MedCenter automated dispensing and medication management systems. These self-service kiosks integrate advanced robotics, secure networks, and two-way video teleconferencing to allow patients to receive dispensed prescriptions and consult with a remote pharmacist. The system aims to streamline the prescription fulfillment process, extending pharmacy services into various accessible locations.
The company was established in 2012, founded on the insight that traditional pharmacy models presented access and convenience challenges for many patients. MedAvail sought to bridge this gap by enabling on-demand prescription access coupled with professional pharmacist oversight, making healthcare more readily available and efficient. This approach addressed the need for a scalable solution to enhance medication adherence and patient engagement.
MedAvail primarily serves health systems, retailers, and medical clinics, enabling them to offer enhanced pharmacy services directly to their patient populations. The company's vision is to transform the accessibility of prescription medications by bringing greater convenience, automation, and integrated care to patients and members across diverse healthcare settings.
MedAvail has raised $147.6M across 4 funding rounds.
MedAvail has raised $147.6M in total across 4 funding rounds.
MedAvail has raised $147.6M across 4 funding rounds. Most recently, it raised $84.0M Other Equity in November 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 18, 2020 | $84M Venture Round | Frank YU | Adage Capital Management, Cigna Ventures, Cowen Healthcare Investments, Heights Capital Management, Lewis & Clark Ventures, Maven Investment Partners, Pura Vida Investments, Redmile Group | Announced |
| Jul 25, 2018 | $16.6M Venture Round | Glen Stettin, Helen Ciesielski | Adage Capital Management, Deerfield Management, Pura Vida Investments, Dave Rawlins | Announced |
| Jul 1, 2018 | $17M Series D | — | HC9 Ventures | Announced |
| Oct 17, 2014 | $30M Series C | Frank Litvack | Adage Capital Management, Deerfield Management, Redmile Group, Walgreens, Walgreens Boots Alliance | Announced |
MedAvail is a healthcare technology company that builds pharmacist-controlled, self-service medication dispensing kiosks (MedCenter) and embeds pharmacy services into clinics and other points of care to improve access to prescription and OTC medications for employers, clinics, hospitals and retail partners.[1][5]
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: MedAvail addresses a clear, pragmatic problem—bringing pharmacist‑supervised dispensing to the point of care—by combining secure dispensing hardware with telepharmacy and software; its future depends on scaling partnerships, regulatory alignment, and proving sustainable unit economics as the point‑of‑care pharmacy trend grows.[1][5]
Limitations / Sources: The above synthesis is based on the company profiles and coverage available from CB Insights, Built In, ZoomInfo and OTC Markets, which summarize MedAvail’s product, founding year and commercial focus but do not provide a full founder biography or detailed financials in the cited pages.[1][2][3][5]
MedAvail has raised $147.6M in total across 4 funding rounds.
MedAvail's investors include Frank Yu, Adage Capital Management, Cigna Ventures, Cowen Healthcare Investments, Heights Capital Management, Lewis & Clark Ventures, Maven Investment Partners, Pura Vida Investments, Redmile Group, Glen Stettin, Helen Ciesielski, Deerfield Management.